Cargando…

Complete response of locally advanced cutaneous squamous cell carcinoma of the eyelid to topical imiquimod 3.75%

Detalles Bibliográficos
Autores principales:	Toso, Francesco, Tronconi, M. Chiara, Cortese, Andrea, Fiorillo, Giovanni, Bressan, Alessandra, Costanzo, Antonio, Borroni, Riccardo G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2022
Materias:	Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9786355/ https://www.ncbi.nlm.nih.gov/pubmed/36066074 http://dx.doi.org/10.1111/dth.15800

Ejemplares similares

Acantholytic Pityriasis Rubra Pilaris Associated with Imiquimod 3.75% Application
por: Atanaskova Mesinkovska, Natasha, et al.
Publicado: (2011)

Usefulness of Topical Imiquimod 3.75% in Cytokeratin 7 Positive Extramammary Paget Disease of the Vulva: Towards Personalized Therapy
por: Mazzilli, Sara, et al.
Publicado: (2021)

Case of large lentigo maligna melanoma of the scalp treated with 5% and 3.75% Imiquimod()()
por: Rovesti, Miriam, et al.
Publicado: (2021)

Leukocytoclastic vasculitis (cutaneous small-vessel vasculitis) after COVID-19 vaccination
por: Fiorillo, G., et al.
Publicado: (2022)

Cost-efficacy analysis of 3% diclofenac sodium, ingenol mebutate, and 3.75% imiquimod in the treatment of actinic keratosis
por: Nisticò, Steven, et al.
Publicado: (2018)

Case of giant vulvar condyloma acuminata successfully treated with imiquimod 3.75% cream: A case report
por: Hum, Matthew, et al.
Publicado: (2018)

Frontal Fibrosing Alopecia Associated With Oral Erosive Lichen Planus: Two Locations, One Disease
por: Toso, Francesco, et al.
Publicado: (2023)

Imiquimod 3.75% for field‐directed therapy of actinic keratosis: results of a prospective case‐series study in Greece
por: Befon, Angeliki, et al.
Publicado: (2019)

Treatment of Cutaneous Tumors with Topical 5% Imiquimod Cream
por: Alessi, Sabrina Sisto, et al.
Publicado: (2009)

Old World Cutaneous Leishmaniasis: Successful response to topical imiquimod
por: Llamas-Molina, Jose M., et al.
Publicado: (2022)

Imiquimod 3.75% Cream Applied Daily to Treat Anogenital Warts: Combined Results from Women in Two Randomized, Placebo-Controlled Studies
por: Baker, David A., et al.
Publicado: (2011)

Earliest stage treatment of actinic keratosis with imiquimod 3.75% cream: Two case reports—Perspective for non melanoma skin cancer prevention
por: Kopera, Daisy
Publicado: (2020)

Sorafenib-Induced Acute Generalized Exanthematous Pustulosis
por: Cortese, Andrea, et al.
Publicado: (2023)

Treatment of locally advanced cutaneous Merkel cell carcinoma with topical imiquimod
por: Saini, Komal, et al.
Publicado: (2021)

Topical imiquimod in combination with brachytherapy for unresectable cutaneous melanoma scalp metastases
por: Yeh, Jennifer E., et al.
Publicado: (2022)

Topical imiquimod for the palliative treatment of recurrent oral squamous cell carcinoma
por: Wester, Annie, et al.
Publicado: (2017)

A case report of imiquimod topical therapy as treatment for cutaneous metastasis of breast cancer
por: Nguyen, Anthony L, et al.
Publicado: (2021)

Topical Imiquimod Treatment of Lentigo Maligna
por: Ventura, F., et al.
Publicado: (2009)

Topical Imiquimod for the Treatment of Relapsed Cutaneous Langerhans Cell Histiocytosis after Chemotherapy in an Elderly Patient
por: Imashuku, Shinsaku, et al.
Publicado: (2018)

Topical 5% Imiquimod Sequential to Surgery for HPV-Related Squamous Cell Carcinoma of the Lip
por: Pentangelo, Giovanni, et al.
Publicado: (2021)

Eyelid Cutaneous Horn
por: Sadeghi, Ezatollah, et al.
Publicado: (2012)

Topical Application of Imiquimod as a Treatment for Chromoblastomycosis
por: de Sousa, Maria da Glória Teixeira, et al.
Publicado: (2014)

Lichenoid keratosis successfully treated with topical imiquimod
por: BinJadeed, Hessah, et al.
Publicado: (2020)

Pseudolymphoma of the nipple treated with topical imiquimod and cryotherapy
por: Xiao, Amy, et al.
Publicado: (2022)

Imiquimod - Its role in the treatment of cutaneous malignancies
por: Bubna, Aditya Kumar
Publicado: (2015)

Phospholipid-Based Microemulsions for Cutaneous Imiquimod Delivery
por: Panoutsopoulou, Eleni, et al.
Publicado: (2022)

Eyelid Lentigo Maligna Treated With Imiquimod 5%: Should We Fear of Ocular Side Effects?
por: Conforti, Claudio, et al.
Publicado: (2023)

Cutaneous Anthrax on the Upper Eyelid
por: Celik, Ekrem, et al.
Publicado: (2021)

Topical Imiquimod for the Treatment of High-Grade Squamous Intraepithelial Lesions of the Cervix: A Randomized Controlled Trial
por: Fonseca, Bruno O., et al.
Publicado: (2021)

Advances in the use of topical imiquimod to treat dermatologic disorders
por: Lacarrubba, Francesco, et al.
Publicado: (2008)

Penile pyoderma gangrenosum successfully treated with topical Imiquimod
por: Rathod, Santosh P., et al.
Publicado: (2011)

A cutback in Imiquimod cutaneous toxicity; comparative cutaneous toxicity analysis of Imiquimod nanotransethosomal gel with 5% marketed cream on the BALB/c mice
por: Jamshaid, Humzah, et al.
Publicado: (2022)

Treatment of recurrent mucosal melanoma of the oral cavity with topical imiquimod and pembrolizumab achieves complete histopathologic remission
por: Satish, Tejus, et al.
Publicado: (2021)

Primary Cutaneous Mucinous Carcinoma of the Eyelid
por: Smith, Katherine, et al.
Publicado: (2017)

Primary Cutaneous Mucinous Carcinoma of the Eyelid
por: Tak, Min Sung, et al.
Publicado: (2016)

Clearance of folliculotropic and tumor mycosis fungoides with topical 5% imiquimod
por: Gordon, Matthew C., et al.
Publicado: (2015)

Repigmentation of gray hairs with lentigo maligna and response to topical imiquimod
por: Lackey, Alexandra E., et al.
Publicado: (2019)

Oral florid papillomatosis: Topical treatment with 5% imiquimod in orabase
por: Ruiz‐Huertas, Pedro, et al.
Publicado: (2022)

Pityriasis rubra pilaris induced by topical use of imiquimod 5%()
por: Armillas-Lliteras, Lucia, et al.
Publicado: (2023)

Topical Calcipotriol Plus Imiquimod Immunotherapy for Nonkeratinocyte Skin Cancers
por: Azin, Marjan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_orc0d206t56g95c9qdcvv1j88e